P. Ragno

C. Selleri, P. Ragno, N. Montuori, 2012, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?

G. Rossi, V. Visconte, P. Ragno, 2005, Thrombosis and Haemostasis.

The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions*

S. Salzano, G. Rossi, P. Ragno, 2002, The Journal of Biological Chemistry.

Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.

M. Cubellis, F. Blasi, K. Danø, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Polarized secretion of urokinase-type plasminogen activator by epithelial cells.

D. Belin, A. Estreicher, J. Vassalli, 1992, Experimental cell research.

The urokinase receptor: a ligand or a receptor? Story of a sociable molecule

P. Ragno, Pia Ragno, 2006, Cellular and Molecular Life Sciences CMLS.

Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion

A. Lavecchia, Daniela Alfano, L. Formisano, 2015, Oncotarget.

N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor

A. Lavecchia, S. Staibano, G. Marone, 2018, Front. Immunol..

The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor

Daniela Alfano, S. Salzano, G. Rossi, 2011, Cellular and Molecular Life Sciences.

Processing of complex between urokinase and its type‐2 inhibitor on the cell surface

G. Rossi, J. Vassalli, P. Ragno, 1993, FEBS letters.

G-CSF-induced hematopoietic stem cell mobilization The metastasis-associated 67-kDa laminin receptor is involved in

N. Scarpato, G. Rossi, V. Visconte, 2008 .

hematopoietic stem cell mobilization Involvement of the urokinase-type plasminogen activator receptor in

G. Rossi, F. Blasi, V. Visconte, 2008 .

Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells.

G. Rossi, G. Høyer-Hansen, B. Covelli, 1998, Cancer research.

In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.

G. Rossi, V. Visconte, B. Rotoli, 2006, Cancer research.

Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR.

P. Ragno, N. Montuori, 2009, Frontiers in bioscience.

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications

P. Ragno, F. Napolitano, N. Montuori, 2021, International journal of molecular sciences.

Urokinase‐type plasminogen activator up‐regulates the expression of its cellular receptor

S. Salzano, G. Rossi, P. Ragno, 2000, FEBS letters.

Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the c

G. Rossi, P. Ragno, N. Montuori, 1995, European journal of biochemistry.

Urokinase‐type plasminogen activator up‐regulates the expression of its cellular receptor through a post‐transcriptional mechanism

M. Caputi, G. Rossi, A. Mattiello, 2001, FEBS letters.

uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors

Daniela Alfano, P. Ragno, V. Cosimato, 2012, Thrombosis and Haemostasis.

RhoB regulates uPAR signalling

A. Ridley, Daniela Alfano, M. Stoppelli, 2012, Journal of Cell Science.

67 kDa laminin receptor: structure, function and role in cancer and infection.

C. Selleri, A. de Paulis, P. Ragno, 2012, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment

G. Høyer-Hansen, A. Salvati, C. Selleri, 2016, Oncotarget.

Upregulation of the N-Formyl Peptide Receptors in Scleroderma Fibroblasts Fosters the Switch to Myofibroblasts

S. Staibano, G. Marone, G. Di Spigna, 2015, The Journal of Immunology.

Posttranscriptional Regulation of the Plasminogen Activation System by Non-Coding RNA in Cancer

P. Ragno, M. Alfieri, Luigi Meo, 2023, International journal of molecular sciences.

Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer

C. Selleri, A. de Paulis, P. Ragno, 2016, Translational medicine @ UniSa.

CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines

A. Laurenzana, F. Bianchini, A. Biagioni, 2021, Frontiers in Oncology.

Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.

L. del Vecchio, G. Rossi, B. Rotoli, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.

Ettore Novellino, Antonio Lavecchia, Pia Ragno, 2012, Journal of medicinal chemistry.

Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells

C. Selleri, P. Ragno, V. Giudice, 2022, Cancers.

Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells

Daniela Alfano, C. Selleri, P. Ricci, 2015, Journal of cellular and molecular medicine.

Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.

C. Selleri, P. Ragno, A. Pesapane, 2017, Current pharmaceutical design.

Expression and Functions of the Vascular Endothelial Growth Factors and Their Receptors in Human Basophils1

D. Ribatti, S. Staibano, G. Marone, 2006, The Journal of Immunology.

TLR4 Response to LPS Is Reinforced by Urokinase Receptor

S. Rong, H. Haller, P. Ragno, 2020, Frontiers in Immunology.

Discovery of New Small Molecules Targeting the Vitronectin-Binding Site of the Urokinase Receptor That Block Cancer Cell Invasion

A. Lavecchia, C. Di Giovanni, A. de Paulis, 2013, Molecular Cancer Therapeutics.

Small Molecule Therapeutics Discovery of New Small Molecules Targeting the Vitronectin-Binding Site of the Urokinase Receptor That Block Cancer Cell Invasion

A. Lavecchia, P. Ragno, F. Rossi, 2013 .

A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs

P. Ragno, N. Montuori, M. Alfieri, 2018, Oncotarget.

New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms

A. Petrone, P. Ragno, N. Montuori, 2020, Cells.

The Urokinase Receptor Takes Control of Cell Migration by Recruiting Integrins and FPR1 on the Cell Surface

Daniela Alfano, P. Remondelli, G. Amodio, 2014, PloS one.

Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 21

G. Marone, G. Rossi, V. Visconte, 2004, The Journal of Immunology.

Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence

Pia Ragno, Simona Losito, D. Rea, 2014, Oncotarget.

PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer

M. Acunzo, G. Romano, M. Garofalo, 2008, Journal of cellular and molecular medicine.

Echographic Diagnosis of Omphalocele in the First Trimester of Pregnancy

P. Ragno, M. Pagliano, M. Mossetti, 1990, Journal of clinical ultrasound : JCU.

This information is current as Receptors in Human Basophils Endothelial Growth Factors and Their Expression and Functions of the Vascular

Stefania Staibano, Francesca Rossi, Gianni Marone, 2006 .

Production of urokinase-type plasminogen activator by normal and transformed rat thyroid cells in culture.

G. Rossi, F. Blasi, P. Ragno, 1989, Experimental cell research.

Cleavage of urokinase receptor regulates its interaction with integrins in thyroid cells

G. Rossi, P. Ragno, N. Montuori, 1999, FEBS letters.

The Plasminogen Activator System in Fibroblasts from Systemic Sclerosis

S. Salzano, G. Di Spigna, G. Rossi, 2010, International journal of immunopathology and pharmacology.

Urokinase-type plasminogen-activator and normal thyroid cell adhesion to the extracellular matrix.

S. Salzano, G. Rossi, P. Ragno, 1999, Biochimie.

Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion

A. Lavecchia, Daniela Alfano, L. Formisano, 2015, Oncotarget.

Hp(2-20) peptide of Helicobacter pylori and the innate immune receptors: specific role(s) of the formyl peptide receptors.

C. Selleri, A. de Paulis, P. Ragno, 2012, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.